(Photo=CJ CheilJedang) The idea that beauty can be maintained from within—through what consumers eat and drink—has moved from niche wellness circles into the U.S. mainstream. Capsules, powders and functional beverages promising skin benefits have proliferated, but so has skepticism. Retailers and regulators are increasingly demanding hard evidence to support claims long driven by marketing. That shift is reshaping competition in

Photo=Motionelements South Korea’s startup formation is shrinking overall, but beneath the headline decline a structural shift is taking shape—one that is steadily tilting the country’s entrepreneurial landscape toward technology-driven sectors. Data released by the Ministry of SMEs and Startups show that 1.14 million new businesses were established in 2025, down 4.0% from a year earlier and marking the fifth consecutive

(Photo=Hanmi Pharmceutical) A takeover agreement between Hanmi Pharmaceutical and Aptose Biosciences is drawing attention in U.S. biotech circles, as a mid-sized South Korean drugmaker moves to secure a direct operating base in North America’s cancer drug market. Hanmi Pharmaceutical, founded in 1973 and one of South Korea’s leading research-driven pharmaceutical companies, has built its global presence largely through licensing deals

Photo=Hyundai Motor Company Hyundai Motor Company is moving to formally enter the car-rental business as it upgrades its vehicle-subscription platform and expands further into mobility services. The company plans to seek shareholder approval on March 26 (local time) to add “automobile rental business” to its corporate objectives at its annual general meeting. The move would allow Hyundai to directly provide

Photo=Motionelements For decades, the global market for hair-loss treatments has been defined less by breakthrough innovation than by incremental improvement. A handful of oral drugs have dominated prescriptions, offering measurable but often incomplete results, accompanied by side effects that have limited broader adoption. Now, a new wave of therapies is raising a familiar question in the pharmaceutical industry: can hair